ÐÓ°ÉÂÛ̳

Efficiency

The efficiency of pharmaceutical spending in England: the impact of NICE recommendations on the NHS are empirically evaluated.

 Efficiency of pharmaceutical spending in England

ÐÓ°ÉÂÛ̳ Principal Investigator: Huseyin Naci
Start Date: May 2023
End Date: December 2023
Regions: UK
Countries: UK
Keywords: pharmaceutical policy, prescription drugs

The National Institute for Health and Care Excellence (NICE) in England is tasked with recommending to the NHS whether new drugs should be reimbursed. NICE relies on cost-effectiveness analyses to determine whether new drugs offer good value for money for the NHS. However, the impact of NICE recommendations on the NHS has not been empirically evaluated. This project evaluates the efficiency of pharmaceutical spending in England. 

Topic classification: Health policy, health technology regulation & assessment

Check back later for our latest Twitter updates.

Contact us

Telephone

Centre Manager +44 (0)20 7955 7392

Events, Comms & General Enquiries +44 (0)20 7107 5696

Address

ÐÓ°ÉÂÛ̳ Health, Cowdray House, London School of Economics and Political Science, Houghton Street, London WC2A 2AE